Moberg Pharma
7.795
SEK
-1.33 %
Less than 1K followers
MOB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-1.33%
-1.58%
-17.51%
-23.35%
-35.1%
-76.49%
-53.96%
-88.76%
-86.95%
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Read moreMarket cap
373.22M SEK
Turnover
210.31K SEK
Revenue
9.81M
EBIT %
-3,311.21 %
P/E
-
Dividend yield-%
-
Financial calendar
13/5
2025
Interim report Q1'25
22/5
2025
General meeting '25
12/8
2025
Interim report Q2'25
All
Webcasts
Press releases
ShowingAll content types
Notice of Annual General Meeting in Moberg Pharma AB (publ)
Moberg Pharmas årsredovisning för räkenskapsåret 2024 offentliggjord
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools